Which disease patients are not recommended to be treated with COVID-19 Intensive Acupuncture, which are high-risk groups

Who can be vaccinated with COVID-19 Vaccine

China has laid out five technical routes to research and develop COVID-19 vaccine, including inactivated vaccine, recombinant protein vaccine, adenovirus vector vaccine, attenuated influenza virus vector vaccine and nucleic acid vaccine.

First of all, you must carefully read the informed consent form before you vaccinate COVID-19 vaccine. If you are temporarily unwell, you must postpone the vaccination.

And individuals who are not between the ages of 18-59 are temporarily not eligible for vaccination and will continue to wait for the results of clinical trial data to determine if vaccination is possible before continuing.

Second, like other vaccines, if the vaccine is allergic to the main components of the vaccine, the use of COVID-19 vaccine should be prohibited. Thirdly, suffering from malignant tumor diseases; There are underlying diseases, such as hypertension and patients with illnesses; Suffering from mental illnesses; Cardiovascular and cerebrovascular diseases are in an unstable phase; There are some hereditary diseases in families; Having undergone surgeries for heart disease, such as bypass grafting, stents, etc; There are also patients in the recovery period after major surgery who are temporarily not eligible for vaccination. Fourthly, pregnant or lactating women should also temporarily suspend vaccination. Some couples who are currently preparing or have recently received other inactivated or attenuated vaccines should postpone their vaccination time. Fifth, patients with fever, acute illness, or sexual diseases, as well as some patients currently receiving immunosuppressive therapy, are temporarily not suitable for vaccination. Once the clinical trial can obtain sufficient clinical research data to prove that the vaccine has sufficient protective efficacy, acceptable safety basis, and stable commercial scale production quality, the applicant can submit the vaccine's marketing application.

What kind of people can get COVID-19 vaccine

Since July, China has completed more than 1 million doses of COVID-19 vaccine emergency vaccination.

Through adverse reaction monitoring and follow-up observation, no serious adverse reactions have occurred in the population vaccinated with COVID-19 vaccine in China. Vaccination with any vaccine may result in adverse reactions. Mild adverse reactions such as local pain and redness are normal.

The official also said that at present, only high-risk people are recommended to be vaccinated with COVID-19 vaccine, and ordinary people do not have to be vaccinated. For example, the risk of infection among healthcare workers, customs officials, and overseas workers is definitely higher than that of ordinary people; People with cardiovascular and pulmonary diseases have a high probability of developing critical illnesses, so they naturally need priority vaccination. The reason for this regulation is mainly because the domestic epidemic control is very good, and the risk of infection for ordinary people is extremely low.

At present, there are hundreds of units in the research and development of COVID-19 vaccine worldwide, mainly focusing on several technical routes, including inactivated vaccine, gene recombinant vaccine, vector vaccine (including adenovirus vector, attenuated influenza virus vector), nucleic acid vaccine (mRNA vaccine, DNA vaccine).

These 5 technological routes cannot be simply said to be better. To evaluate a vaccine, it is necessary to comprehensively consider its safety, effectiveness, accessibility, and affordability. This is the scientific evaluation of a vaccine.